CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged
时间:2024-06-26 08:03:58 阅读(143)
The Central Drugs Standard Control Organisation (CDSCO) has flagged 62 drug samples as they failed the quality test. The alert was issued by the drug regulator for November 2023.
The drug regulator’s list, as seen by Financial Express.com, reveals that 1197 drug samples were tested, out of which 1133 samples were of standard quality. 62 samples were not of standard quality, one sample was spurious and one sample was misbranded.
According to the drug regulator, dissolution, disintegration and assay are some of the reason of drug test failure. Lupin, Jackson Laboratories, E.G. Pharmaceuticals, Konis Pharmaceuticals, Biozenta Lifesciences Pvt., Aristo Pharmaceuticals, and Cotec Healthcare are some of the companies whose drug failed the quality test.
The regulator also issued a revised drug Alert for May 2022 which Omeprazole (Delayed-Release) and Domperidone (Sustained Release) Capsules, manufactured by Dr. Reddy’s Laboratories. CDSCO maintains that the assay of Omeprazole and Domperidone is the reason of failure.
“The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of investigation,” it stated.
The drug combination belongs to a group of medicines called gastrointestinal agents used to treat heartburn, indigestion, epigastric pain, gastro-oesophageal reflux disease (GERD), peptic ulcers and Zollinger-Ellison syndrome.
上一篇:FII DII data- FPI sold shares worth Rs 1975
下一篇:Yes Bank shares drops over 2 per cent after June quarter earnings
猜你喜欢
- Will Nifty hold 21,500 levels or Hit a new high of 22,000- See GIFT Nifty, FII data, F&O ban, crude, more before market opens
- ZEE5 Global launches campaign ‘The Great ZEE5 Giveaway’
- CLSA bullish on IndusInd Bank, Wipro, Star Health stocks, says sell Maruti Suzuki; check target prices
- Crude oil price falls, unexpected build in crude, fuel inventories in US ignites demand concerns
- Coal India share sale over-subscribed, govt to get more than Rs 4,000 crore
- Crude oil rebounds as China demand recovery optimism supports prices
- FirstCry IPO to see Ratan Tata sell all his shares; SoftBank, M&M and TPG to also offload shares
- Coal India rating – Hold- A good final quarter for company
- Comex gold sees selling pressure near resistance of $1987; Silver may move in a broader range of $23